Status:
UNKNOWN
Vitamin D Deficiency and Effect of Its Supplementation on Interstitial Lung Diseases(ILD).
Lead Sponsor:
Cairo University
Collaborating Sponsors:
Samah Selim Abdel Naiem Selim
Naglaa Bakry Ahmed Elkhatib
Conditions:
Lung Diseases, Interstitial
Vitamin D Deficiency
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
This study evaluates serum level of Vitamin D in Interstitial Lung Diseases in patients with Interstitial Lung Diseases other than connective tissue diseases associated-Interstitial Lung Diseases and ...
Detailed Description
Pulmonary fibrosis was due to chronic inflammation and disordered wound healing in response to damage induced by a variety of agents such as viral infection and radiotherapy or environmental toxins.it...
Eligibility Criteria
Inclusion
- patients who will be diagnosed as interstitial lung disease by multidisciplinary approach based on clinical, functional, radiological and pathological diagnosis when needed.
Exclusion
- Patients who have other diseases affecting Vitamin D levels like chronic liver diseases, chronic kidney diseases and malignancy.
- patients who will be unable to do pulmonary functions or 6-minutes walk test.
- patients with ischemic heart diseases and congestive heart failure.
- patients with connective tissue-associated interstitial lung diseases.
- interstitial lung diseases exacerbation.
Key Trial Info
Start Date :
March 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2020
Estimated Enrollment :
104 Patients enrolled
Trial Details
Trial ID
NCT04100226
Start Date
March 1 2019
End Date
January 1 2020
Last Update
September 24 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Cairo University
Cairo, Egypt, 12613